SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

NOVARTIS: Click to view the issuer\'s details

Last update : 28/01/2011  >View issuer details

2020.05.06 | 20:29 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14 - HTML (w)

2020.04.29 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis Cosentyx® gains fourth indication in EU with first-in-class approval in axial spondyloarthritis spectrum - HTML (w)

2020.04.22 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma - HTML (w)

2020.04.20 | 07:32 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients - HTML (w)

2020.04.20 | 07:17 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye” - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1314